How many investments has Toronto Innovation Acceleration Partners made?

Toronto Innovation Acceleration Partners has 45 tracked investments.

What stage does Toronto Innovation Acceleration Partners invest at?

Toronto Innovation Acceleration Partners invests at the Pre-Seed, Seed stages.

What sectors does Toronto Innovation Acceleration Partners focus on?

Toronto Innovation Acceleration Partners focuses on Biotech, Digital Health, Healthtech, Medical Devices.

Where is Toronto Innovation Acceleration Partners located?

Toronto Innovation Acceleration Partners is headquartered in Toronto, CA.

Who does Toronto Innovation Acceleration Partners co-invest with?

Toronto Innovation Acceleration Partners most often shares deals with Lumira Ventures, FACIT (Fight Against Cancer Innovation Trust), Stand Up Ventures, among 34 tracked co-investors.

Toronto Innovation Acceleration Partners

Venture studio

Toronto · Pre-Seed–Seed · 11 people tracked

★ Follow + Add to CRM ⤳ Find an introduction

✨ Fox Verdict

Investment thesis

TIAP focuses on venture building of early-stage health science technologies emerging from its academic member institutions. It transforms early-stage scientific innovations into business ventures, de-risks ideas through expert financial and scientific advice, invests in early-stage innovations, and sources external venture capital for future funding. TIAP leverages a global and local network to connect industry, researchers, investors and members. It offers cornerstone programs and management support including LAB150-NextGen, UTEST, Venture Builder, Critical Technologies and Portfolio Management to advance inventions toward a market-ready state.

Invests inBiotech Digital Health Healthtech Medical Devices Canada Toronto

Source: firm website, verified Aug 3, 2026.

Stage

Pre-Seed–Seed

Toronto, CA

Instruments

Equity

Founded

2008

Tracked investments

Team · 11 people

from the firm's website

Barry Gee· Director, Public Affairs· Vancouver, British Columbia, Canadain

Barry Gee has more than 20 years of experience in strategic communications and stakeholder relations, primarily with Canadian health and life science organizations. He spent over a decade on the executive team at adMare BioInnovations and its predecessor, the Centre for Drug Research and Development (CDRD), serving as Senior Director of Communications and External Relations, and previously held roles at LifeSciences British Columbia, Innovate BC, and the federal Pacific Forest Research Centre. He holds a B.A. in Creative Writing from the University of Victoria.

Chris Adams· Part-time CFO· Toronto, Ontario, Canadain

Chris Adams is a CPA/CA with more than thirty years of experience who has provided bookkeeping, accounting, financial reporting, SR&ED, and corporate tax compliance services to early-stage technology companies and nonprofits since 2006. As part-time CFO at TIAP, he oversees accounting functions and both internal and external financial reporting. He holds a Bachelor of Commerce from the University of Toronto and earned his accounting designation while training at KPMG.

Diana Resetca· Analyst, Technology and Venture Development

Diana Resetca joined TIAP in 2020 as an Analyst, Technology and Venture Development, supporting technology commercialization efforts and the LAB150 program. Working with the Life Sciences team and researchers at member institutions, she conducts scientific due diligence, market research, and competitive analysis to assess venture projects. She previously worked with local AI and biotechnology startups and nonprofits as an analyst and scientific consultant, holds an MSc in Chemistry from York University and a BSc in Biology and Chemistry from the University of Toronto, and has published research in journals including Nature Structural and Molecular Biology and Molecular Cell.

Dr. Angela Zhou· Analyst, Technology & Venture Development

Angela Zhou joined TIAP after working on two University of Toronto strategic initiatives, Medicine by Design and the Precision Medicine Initiative (PRiME), where she developed and managed funding and training programs connecting scientists, engineers, and clinicians in regenerative and precision medicine. She previously consulted for Turnstone Biologics on technical and regulatory writing and pre-clinical research support, and has served as Managing Editor of RCIScience and co-chaired the Canadian Science Policy Centre's Program Committee. She holds a PhD in Immunology and a BSc in Physiology and Immunology, both from the University of Toronto.

Dr. Phil Goldbach· Director, Technology and Venture Development

Phil Goldbach manages intellectual property across TIAP's (formerly MaRS Innovation) portfolio, advising on IP protection, patentability, and patent application filings, and he also manages projects in the Life Sciences portfolio while conducting technical and market due diligence on new technologies. Before TIAP, he trained at an intellectual property boutique law firm in Toronto within its life sciences patent practice and served as director of intellectual property for a Mississauga biotechnology startup focused on antibody-based products for animal health and food safety. He holds a PhD in Molecular Genetics from the University of Toronto and a JD from Osgoode Hall Law School.

Dr. Sohaib Siddiqui· Director, Technology & Venture Development

Sohaib Siddiqui provides medical, scientific, and business support to early-stage startups at TIAP, working with academic and institutional partners to identify medical technologies in digital health and medical devices. Before TIAP, he managed healthcare strategy at Kettlebeck Ventures, a family-office backed healthcare fund, and trained as a medical doctor and pediatric clinical researcher. He also holds an Innovation Fellow appointment at Women's College Hospital and earned degrees from Queen's University, the Royal College of Surgeons in Ireland, and a digital health certificate from Harvard Medical School.

Ido Kaminsky· Director, Technology and Venture Development· Vaughan, Ontario, Canadain

Ido Kaminsky was previously Director of Business Analysis at FutuRx, a biotech incubator backed by JJDC (J&J), Takeda Ventures, and Orbimed Israel, where he handled scouting, deal flow, scientific and business analysis, IP licensing, and venture formation, contributing to the launch of more than 10 biotechnology startups. He earlier worked at RM Global Partners, a boutique investment bank in the pharma, biotech, and medical-device sectors, and as an analyst at the Frankel Group, a life-science strategic consulting firm. He holds an M.Sc. in biochemistry from the Weizmann Institute of Science.

Michelle Kirkwood· Senior Director and HR Business Partner· Ajax, Ontario, Canadain

Michelle Kirkwood is an HR leader with experience in the financial and health care sectors, focused on organizational design and large-scale change management initiatives. She joined UHN in November 2020 and serves as the People & Culture partner for the Corporate Portfolio, UHN Retention Strategy, and UHN partner organizations, including acting as HR strategic partner to TIAP's CEO and team. She is a change management practitioner and participates on a burnout committee supporting interventions at Princess Margaret Hospital and the Peter Munk Cardiac Centre.

Mobeen Lalani· Manager, Technology and Venture Development; Co-Director, University of Toronto Early-Stage Technology (UTEST) program· Ontarioin

Mobeen Lalani manages technology and venture development at TIAP and co-directs the University of Toronto Early-Stage Technology (UTEST) program, where he works on identifying and commercializing health technologies, leading due diligence, market analysis, and technology development planning. He previously held sales and business development leadership roles at a telehealth startup and worked on healthcare innovation and strategy for a large Canadian pharmacy retailer, as well as health data transformation in primary care. He holds a Master of Health Informatics and a Bachelor of Science in Molecular Biology and Population Health from the University of Toronto and a certificate in Health Law and AI in Healthcare from the University of Ottawa.

Prakash Gowd· Vice President; Interim President & CEO· Greater Toronto Area, Canadain

Prakash Gowd joined TIAP in January 2024 as Vice President and became Interim President & CEO in April 2026. He has over 25 years of experience across biopharma, capital markets, and entrepreneurship, previously serving as COO and Head of Corporate Development at a mental health and psychedelic medicine company and as co-founder of a health technology company, both of which he helped take through public listing or acquisition. Earlier in his career he held biotech equity research and investment banking roles at CIBC World Markets, National Bank Financial, and Canaccord Capital, and he holds an MBA from McGill University plus Pharmacy and Zoology degrees from the University of British Columbia.

Susanne Staer· Corporate Secretary· Toronto, Ontario, Canadain

Susanne Staer is the Corporate Secretary at Toronto Innovation Acceleration Partners (TIAP), responsible for the organization's governance framework, board administration, annual general meetings, and record keeping. She also handles executive office administration and oversees marketing, external communications, social media, and website development. Before TIAP, she supported senior partners at a national law firm in mergers and acquisitions, corporate finance and securities, and previously worked in the Danish diplomatic corps with postings at Royal Danish Embassies in Russia and Ghana.

What they invest in

from 34 of 45 portfolio companies

Healthtech ×17Biotech ×13Medical Devices ×13AI & Machine Learning ×11Deep Tech ×10Digital Health ×7SaaS ×4Cleantech ×2

HQs:Canada×8

Investments · 45 tracked

founders shown can be your intro path

By year:2024 · 1 2018 · 12 dated

7D Surgical7dsurgical.com inSep 2018

7D Surgical develops image-guided surgical navigation systems using machine-vision technology for spine, cranial, and percutaneous procedures.

AI & Machine LearningHealthtechMedical Devices

STEPHEN MARTIN(Executive Officer)MICHAEL CADOTTE(Director)VICTOR YOUNG(Executive Officer, Director)ADRIAN LINUS DINESH MARIAMPILLAI(Executive Officer, Director)MICHAEL APKON(Director)BEAU STANDISH(Executive Officer, Director)

Amacatheraamacathera.ca in

AmacaThera develops a clinically validated hydrogel platform for localized, sustained release of therapeutics, partnering with pharmaceutical companies to enhance existing and emerging drug candidates.

BiotechHealthtechMedical DevicesNew MaterialsToronto, CA

Mike Cooke(Co-Founder & CEO)Molly Shoichet(Co-Founder & Chief Science Officer)

Co-investorsLumira Ventures Stand Up Ventures

Ardrabioardrabio.com in

Ardra Bio produces sustainable ingredients for food and beverage formulations from renewable natural substrates, serving environmentally conscious consumers.

BiotechCleantechFoodTech

Bitnobibitnobi.com in 𝕏

Bitnobi is a privacy-focused data sharing platform that enables organizations to share aggregated insights without moving raw data from its source.

Cloud ComputingData & InfrastructureEnterprise Software

Blue Jbluej.com in 𝕏

Blue J is an AI-powered platform providing tax research and analysis tools for tax professionals and accountants across North America and the UK.

AI & Machine LearningLegalTechSaaSToronto, CA

Benjamin Alarie(CEO)inAlbert Yoon(Co-founder)Anthony Niblett(Co-founder)

Co-investorsOak HC/FT Sapphire Ventures Creative Destruction Lab (CDL)Intrepid Growth Partners Mistral Venture Partners Relay Ventures

Bluedotbluedot.global in 𝕏

BlueDot provides AI-powered infectious disease surveillance and intelligence solutions that detect, forecast, and assess outbreak threats for governments, public health organizations, pharmaceutical companies, and enterprises.

AI & Machine LearningGovTechHealthtech

Bresotecbresotec.com

Brightangeltherapeuticsbrightangeltherapeutics.com in 𝕏

Bright Angel Therapeutics develops novel antifungal therapeutics using drug discovery and translational research technologies.

BiotechDeep TechHealthtechMedical DevicesToronto, CA

Leah Cowen(Co-founder & CSO)Luke Whitesell(Co-founder & Consultant)Dominic Jaikaran(President & CEO)

Co-investorsLumira Ventures

Crowdmarkcrowdmark.com in 𝕏

Crowdmark is an AI-powered assessment platform that helps educators grade student assignments and exams faster while providing detailed personalized feedback.

AI & Machine LearningEdTech

Dalriadatxdalriadatx.com in

Dalriada works on covalent drug discovery through collaborations with research institutions like Cleveland Clinic Center for Therapeutics Discovery.

BiotechDeep TechMedical Devices

Damonapharmadamonapharma.com in

Damona develops precision neuromedicines aimed at treating cognitive deficits associated with neurodegenerative and psychiatric disorders such as Alzheimer's disease, depression, and schizophrenia.

BiotechDeep TechDigital HealthHealthtechMedical Devices

Co-investorsAngelini Ventures Lumira Ventures Noetic

Ebt Medicalebtmedical.com in 𝕏

EBT Medical develops neuromodulation technologies targeting the Saphenous nerve to treat pelvic health disorders, particularly overactive bladder.

BiotechMedical Devices

Paul Yoo(Co-founder, President & Chief Scientific Officer)Sasha John(Co-founder and Chief Innovation Officer)Keith R Carlton(Chief Executive Officer)

Co-investorsSV Health Investors Genesys Capital

Fibrocortherapeuticsfibrocortherapeutics.com

Flybitsflybits.com in 𝕏

Flybits provides an AI-powered engagement platform that turns customer data into real-time, personalized experiences for banks and other regulated financial institutions.

AI & Machine LearningFintechMarketing Tech

Co-investorsBosch Ventures Point72 Ventures Robert Bosch Venture Capital Venture Ontario Reinventure Group

Forbiusforbius.com

Co-investorsLumira Ventures

Greymatterneurosciencesgreymatterneurosciences.com

Grey Matter Neurosciences develops non-invasive neuromodulation delivery systems based on focused ultrasound to modulate deep brain circuits.

Deep TechHealthtechMedical Devices

Hdaxtxhdaxtx.com

Hippocamerahippocamera.com

Hypercarehypercare.com

Hypercare is a HIPAA and PHIPA compliant clinical communication platform that provides secure messaging, real-time on-call scheduling, pager replacement, code team activation, and a centralized contact directory.

Digital HealthHealthtechSaaS

Co-investorsFoothill Ventures Nina Capital Wavemaker Three-Sixty Health

InventoRRinventorrmd.ca

Legworkslegworks.com

LegWorks develops prosthetic devices, including its All-Terrain Knee, designed to be lower-cost while maintaining high performance for amputees.

HardwareHealthtechMedical Devices

Co-investorsHouston Angel Network

Loricacyberloricacyber.com in

Lorica.ai provides a platform for deploying AI models with confidential computing and privacy protections, enabling users from individual developers to enterprises to run secure AI workloads without performance degradation.

AI & Machine LearningCloud ComputingCybersecurity

Mazlitemazlite.com in

Mazlite provides AI-driven inline monitoring and optimization for industrial spray painting and powder coating processes.

Advanced ManufacturingAI & Machine LearningIoT

Medlymedly.ca

Medly provides a Class II medical device application and dashboard for remote monitoring and management of chronic conditions, particularly heart failure, for patients and their care teams.

Digital HealthHealthtechMedical DevicesCanada, CA

Co-investorsAda Ventures Eka Ventures FELIX CAPITAL

Micellaemicellae.com in

Micellae develops formulation platforms for creating high-potency, fast-acting drug delivery products in concentrate, powder, and gel formats.

BiotechDeep TechHealthtech

Mutuohealthmutuohealth.com in

Autoscribe is an AI-powered digital scribe that transcribes clinician-patient conversations and automatically generates medical notes for physicians.

AI & Machine LearningDigital HealthHealthtechOntario, CA

Notchtxnotchtx.com

Co-investorsEcoR1 Capital

Odaiaodaia.ai in

ODAIA offers Marketing Intelligence, a platform for pharmaceutical marketing and sales teams that ties channel-level actions to prescription (Rx) outcomes and coordinates healthcare provider (HCP) engagement across digital and field channels.

AI & Machine LearningDigital HealthHealthtechMarketing TechSaaSSales Tech

Philip Poulidis(Founder)in

Co-investorsGraphite Ventures Monograph Capital Partners Panache Ventures Stand Up Ventures Threshold Ventures Wittington Ventures

Otosimotosim.com

Pearlinteractivespearlinteractives.com in

Pearl Interactives develops interactive games and experiences for children that combine physical movement, music, and creative learning with technology like mixed reality and touch-free interfaces.

EdTechGamingHealthtech

Phenomic AIphenomic.ai

Phenomic AI is a biotech company developing therapies for solid tumors using a machine-learning-powered transcriptomics platform that analyzes single-cell RNA data to identify drug targets and understand tumor biology.

AI & Machine LearningBiotechDeep TechToronto, CA

Sam Cooper(Co-founder & CTO)Oren Kraus(Co-founder)

Co-investorsCantos Ventures AV8 Ventures CTI Life Sciences Fund L.P.Garage Capital Hemi Ventures, Llc Hike Ventures +1 more

PhenoTipsphenotips.com in 𝕏

PhenoTips provides a genomic health record and EHR-integrated platform for managing patient pedigrees and genetic analysis.

Digital HealthHealthtechMedical Devices

Co-investorsOntario Centre of Innovation Ontario Centre of Innovation programs Thin Air Labs GreenSky Ventures

Phycusphycusbio.com

Phycus Bio produces Purolic Acid™, a biobased glycolic acid made through fermentation using renewable, FSC-certified wood feedstock for cosmetic, personal care, adhesive, coating, and polymer applications.

BiotechCleantechNew Materials

Co-investorsCircular Innovation Fund Cycle Capital

QD Solarqdsolarinc.com

Qubridgequbridge.io in

Quantum Bridge develops quantum-safe key distribution technology for protecting critical infrastructure and sensitive data against cyber threats.

CybersecurityDeep TechQuantum Computing

Co-investorsGood News Ventures Primo Ventures

Qurcanqurcan.com

QurCan Therapeutics develops nanoparticle drug delivery technology called TERP to create nanomedicines for cancer and central nervous system diseases, with a focus on improving tissue targeting and reducing toxicity associated with existing approaches.

BiotechDeep TechMedical Devices

Co-investorsFACIT (Fight Against Cancer Innovation Trust)

Radialisradialis.com

Radialis develops the Radialis PET Imager, an organ-targeted positron emission tomography system for high-resolution medical imaging of specific tissues and organs.

Deep TechHealthtechMedical Devices

Alla ReznikAndrew DeanCarmel Shields

BoardWayne Schnarr

Co-investorsFACIT (Fight Against Cancer Innovation Trust)

Radiant Biotherapeuticsradiantbio.com inAug 2024

Radiant Biotherapeutics develops a platform of therapeutic molecules called Multabodies that engage multiple disease targets simultaneously within a single engineered protein to treat cancer and infectious diseases.

BiotechMedical Devices

Arthur Fratamico(Executive Officer, Promoter)Deborah Geraghty, Ph.D.(President and Chief Executive Officer)

Co-investorsFACIT (Fight Against Cancer Innovation Trust)

Reeddireeddi.com in 𝕏

A climate-technology company that provides clean energy solutions for homes and businesses, and operates a rental marketplace for equipment and machinery.

B2B MarketplacesClimate TechEnergy

Structurastructura.bio in

Structura develops computational algorithms for analyzing cryo-electron microscopy (cryo-EM) data to determine 3D atomic structures of proteins and biological molecules.

AI & Machine LearningBiotechDeep Tech

Tabiattabiat.care

Tabiat provides a remote care program for COPD (chronic obstructive pulmonary disease) management, offering home monitoring via mobile app, nursing team support, and patient education to reduce hospital readmissions.

Digital HealthHealthtech

Trendmdtrendmd.com

Co-investorsFuel Capital

Vasomunevasomune.com

Vasomune Therapeutics develops investigational medicines, including AV-001, which has received US FDA Fast Track designation.

Biotech

Vitalhubvitalhub.com in

VitalHub provides cloud-based software solutions for health and human services providers, including EHR systems, case management platforms, and operational visibility tools.

Enterprise SoftwareHealthtechSaaS

Zucarazucara.ca

Co-investorsJDRF T1D Fund

Portfolio news

latest coverage across their companies

London’s Medly raises €6.9 million to democratise access to personalised education through an AI tutor

Medly · eu-startups.com · Aug 19, 2026

Frequently asked questions

How many investments has Toronto Innovation Acceleration Partners made?: Toronto Innovation Acceleration Partners has 45 tracked investments.
What stage does Toronto Innovation Acceleration Partners invest at?: Toronto Innovation Acceleration Partners invests at the Pre-Seed, Seed stages.
What sectors does Toronto Innovation Acceleration Partners focus on?: Toronto Innovation Acceleration Partners focuses on Biotech, Digital Health, Healthtech, Medical Devices.
Where is Toronto Innovation Acceleration Partners located?: Toronto Innovation Acceleration Partners is headquartered in Toronto, CA.
Who does Toronto Innovation Acceleration Partners co-invest with?: Toronto Innovation Acceleration Partners most often shares deals with Lumira Ventures, FACIT (Fight Against Cancer Innovation Trust), Stand Up Ventures, among 34 tracked co-investors.

Similar investors

B Capital Group

B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.

$10M – $50M

Breyer Capital

Breyer Capital is a venture capital firm that backs high-impact entrepreneurs, making strategic investments guided by founder passion and its network of experienced investors.

$500K – $10M

DCVC (Data Collective)

DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.

$5M – $25M

Innovestor Ventures

Innovestor is a Finnish investment manager active in venture capital, real estate, and energy storage, and also provides corporate venturing services.

$270K – $3.2M

Khosla Ventures

Khosla Ventures is a venture capital firm that invests in early-stage companies focused on technology, mobile, and clean energy sectors, including biotechnology applications. The firm provides capital and strategic support to entrepreneurs developing breakthrough technologies across multiple markets.

$5K – $50M

Featured in lists

Investors & VC Firms in North America Seed Investors & VC Firms Pre-Seed Investors & VC Firms Seed Investors & VC Firms in North America Healthtech Investors & VC Firms Pre-Seed Investors & VC Firms in North America Healthtech Seed Investors & VC Firms Healthtech Investors & VC Firms in North America Biotech Investors & VC Firms Biotech Seed Investors & VC Firms Medical Devices Investors & VC Firms Healthtech Pre-Seed Investors & VC Firms